| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 11/29/2011 | US8067191 Method for detecting IL-16 activity and modulation of IL-16 activity based on rantes proxy protein levels |
| 11/29/2011 | US8067158 Methods and compositions for the diagnosis and treatment of schizophrenia |
| 11/29/2011 | US8067149 Using stabilizer solutions; removal of cells |
| 11/29/2011 | US8067010 Immunological herpes simplex virus antigens and methods for use thereof |
| 11/29/2011 | US8067001 Antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof |
| 11/29/2011 | US8066998 Antibodies for norovirus |
| 11/29/2011 | US8066994 Proteins comprising an IgG2 domain |
| 11/29/2011 | US8066981 Compositions and methods related to toll-like receptor-3 |
| 11/29/2011 | CA2525657C Human monoclonal antibody specific for lipopolysaccharides (lps) of serotype iats o6 of pseudomonas aeruginosa |
| 11/29/2011 | CA2490027C Directed tissue growth employing reduced pressure |
| 11/29/2011 | CA2484166C Improved chimeric glycoproteins and pseudotyped lentiviral vectors |
| 11/29/2011 | CA2440461C Nucleic acid and corresponding protein entitled 161p5c5 useful in treatment and detection of cancer |
| 11/29/2011 | CA2414331C Pd-l2 molecules: novel pd-1 ligands and uses therefor |
| 11/29/2011 | CA2401438C Novel human ulip/crmp protein and use thereof in diagnosis and treatment of cancers and paraneoplastic neurological syndromes |
| 11/29/2011 | CA2342199C Monoclonal antibodies against s100 |
| 11/29/2011 | CA2292768C Fatty acyl-coa: fatty alcohol acyltransferases |
| 11/24/2011 | WO2011146910A1 Antigen specific tregs and related compositions, methods and systems |
| 11/24/2011 | WO2011146909A1 Tissue fixative having increased viscosity |
| 11/24/2011 | WO2011146524A1 Production of dha and other lc-pufas in plants |
| 11/24/2011 | WO2011146473A1 Methods of treatment using ex vivo expansion of cord blood t cells |
| 11/24/2011 | WO2011145795A1 Cartilage-specific hif-2α transgenic mouse as an animal model for arthritis, and use thereof |
| 11/24/2011 | WO2011145744A1 Anti-human trop-2 antibody having antitumor activity in vivo |
| 11/24/2011 | WO2011145629A2 ANTIBODY CAPABLE OF BINDING TO TRANSFORMING GROWTH FACTOR ALPHA AND HAVING ANTIPROLIFERATIVE ACTIVITY ON CANCER HAVING Ras GENE MUTATION |
| 11/24/2011 | WO2011145615A1 Nucleic acid for production of pluripotent stem cell |
| 11/24/2011 | WO2011145211A1 Ketoreductase mutant |
| 11/24/2011 | WO2011145110A1 A novel cord blood plasma nutrient formulation and a method for the preparation thereof |
| 11/24/2011 | WO2011145015A1 Plants having increased tolerance to herbicides |
| 11/24/2011 | WO2011144956A1 Process for the production of patches or dressings of autologous skin through cultivation of autologous keratinocytes and fibroblasts with autologous serum for the generation of skin |
| 11/24/2011 | WO2011144901A1 Expansion and directed differentiation of epidermal neural crest stem cells |
| 11/24/2011 | WO2011143933A1 Udp-glucose-4-epimerase useful for improving agronomic performance of plants |
| 11/24/2011 | WO2011143922A1 Process for the separation of casparian strip |
| 11/24/2011 | WO2011143802A1 Method for in vitro inducing megakaryocyte progenitor cells and megakaryocytes |
| 11/24/2011 | WO2011143741A1 Extenders for mammalian sperm processing and preservation |
| 11/24/2011 | WO2011109833A3 Induced dendritic cell compositions and uses thereof |
| 11/24/2011 | WO2011106222A3 Modified substrates for protection of peptide-immobilized surfaces from gamma radiation degradation |
| 11/24/2011 | WO2011073261A3 A continuous culturing device |
| 11/24/2011 | WO2011063198A3 Methods and compositions for modulating the activity of the interleukin-35 receptor complex |
| 11/24/2011 | WO2011062909A3 Creating bioengineered lymph nodes |
| 11/24/2011 | WO2011060095A3 Hydrogel-based vascular lineage cell growth media and uses thereof |
| 11/24/2011 | WO2008153685A9 Progenitor cells from urine and methods for using the same |
| 11/24/2011 | US20110289633 Mutated eif4e sequences from potato which are useful in imparting virus resistance |
| 11/24/2011 | US20110289632 Methylketone synthase, production of methylketones in plants and bacteria |
| 11/24/2011 | US20110289631 Method for producing male sterile plants |
| 11/24/2011 | US20110289629 Increasing cell wall deposition and biomass density in plants |
| 11/24/2011 | US20110289628 Polyunsaturated fatty acid elongase |
| 11/24/2011 | US20110289627 Modified cry3a toxins and nucleic acid sequences coding therefor |
| 11/24/2011 | US20110289625 Altered leaf morphology and enhanced agronomic properties in plants |
| 11/24/2011 | US20110289624 Gene-transfer vector comprising helper-component protease gene of papaya ringspot virus for broad-spectrum virus resistance in crops and use thereof |
| 11/24/2011 | US20110289623 Compositions and methods for the modification of gene expression |
| 11/24/2011 | US20110289622 Expression cassettes for transgenic expression of nucleic acids |
| 11/24/2011 | US20110289619 Rice brown planthopper resistance gene and applications thereof |
| 11/24/2011 | US20110289618 Cotton Variety FM 9101GT |
| 11/24/2011 | US20110289617 Cotton Variety FM 9103GT |
| 11/24/2011 | US20110289616 Soybean Cultivar S080093 |
| 11/24/2011 | US20110289615 Soybean Cultivar 8919112 |
| 11/24/2011 | US20110289614 Soybean Cultivar S090018 |
| 11/24/2011 | US20110289613 Soybean Cultivar S090020 |
| 11/24/2011 | US20110289612 Soybean Cultivar S090012 |
| 11/24/2011 | US20110289611 Rna sequence-specific mediators of rna interference |
| 11/24/2011 | US20110289610 Hcv/gbv-b chimeric virus |
| 11/24/2011 | US20110289609 Neurotransmitter Sensors and Methods of Using the Same |
| 11/24/2011 | US20110289608 Antisense modulation of interleukins 17 and 23 signaling |
| 11/24/2011 | US20110289607 Method of inhibiting gene expression |
| 11/24/2011 | US20110289605 Animal Model for Osteoarthritis and Intervertebral Disc Disease |
| 11/24/2011 | US20110289604 Methods for Identifying Modulating Compounds of Lymphangiogenesis, Means Therefore, Compounds and Uses Thereof |
| 11/24/2011 | US20110288272 Modified cry3a toxins and nucleic acid sequences coding therefor |
| 11/24/2011 | US20110288166 Triptolide c-ring derivatives as anticancer agents and immune modulators |
| 11/24/2011 | US20110288161 Methods for treatment of thiol-containing compound deficient conditions |
| 11/24/2011 | US20110288158 Methods and compositions for the specific inhibition of gene expression by double-stranded rna |
| 11/24/2011 | US20110288156 Nucleic Acids, Polypetides, and Methods for Modulating Apoptosis |
| 11/24/2011 | US20110288150 Oligonucleotides for Suppressing Cancer Cell Invasion and Migration |
| 11/24/2011 | US20110288147 Compositions and methods for the specific inhibition of gene expression by DSRNA containing a tetraloop |
| 11/24/2011 | US20110288116 Iap inhibitors |
| 11/24/2011 | US20110288108 Tricyclic compounds having antimitotic and/or antitumor activity and methods of use thereof |
| 11/24/2011 | US20110288103 Compounds, compositions, and methods comprising 1,3,4-oxadiazole derivatives |
| 11/24/2011 | US20110288100 Therapeutic agents useful for treating pain |
| 11/24/2011 | US20110288093 Compounds, Compositions, and Methods Comprising Pyridazine Sulfonamide Derivatives |
| 11/24/2011 | US20110288073 Alpha-Aminocyclolactam Ligands for G-protein Coupled Receptors, and Methods of Using Same |
| 11/24/2011 | US20110288055 Mitoquinone derivatives used as mitochondrially targeted antioxidants |
| 11/24/2011 | US20110288053 Antiviral phosphonate analogs |
| 11/24/2011 | US20110288044 Modulation of sodium channels by nicotinamide adenine dinucleotide |
| 11/24/2011 | US20110288034 Methods of identifying adipocyte specific genes, the genes identified, and their uses |
| 11/24/2011 | US20110288029 Method for inhibiting neuronal cell death |
| 11/24/2011 | US20110288026 Electroprocessed Collagen and Tissue Engineering |
| 11/24/2011 | US20110288021 Administration of angiocidin for the treatment of cancer |
| 11/24/2011 | US20110288019 Methods of increasing platelet and hematopoietic stem cell production |
| 11/24/2011 | US20110288004 Viral Sequences and Uses Thereof |
| 11/24/2011 | US20110287982 Cell culture device |
| 11/24/2011 | US20110287979 Methods for Identifying and Isolating Cells Expressing a Polypeptide |
| 11/24/2011 | US20110287971 Multi-chain eukaryotic display vectors and uses thereof |
| 11/24/2011 | US20110287960 Method For Producing Monoclonal Antibodies |
| 11/24/2011 | US20110287936 Gene switch compositions and methods of use |
| 11/24/2011 | US20110287544 Photobioreactor Systems Positioned on Bodies of Water |
| 11/24/2011 | US20110287543 Cell culture methods and devices utilizing gas permeable materials |
| 11/24/2011 | US20110287542 Cell culture methods and devices utilizing gas permeable materials |
| 11/24/2011 | US20110287541 Accordion bioreactor |
| 11/24/2011 | US20110287540 Method for controlling proliferation of cord blood hematopoietic stem cells and use thereof |
| 11/24/2011 | US20110287539 Optimized Methods for Differentiation of Cells into Cells With Hepatocyte and Hepatocyte Progenitor Phenotypes, Cells Produced by the Methods, and Methods of Using the Cells |
| 11/24/2011 | US20110287538 Method for production of reprogrammed cell using chromosomally unintegrated virus vector |
| 11/24/2011 | US20110287537 Neuroprotective agents for the prevention and treatment of neurodegenerative diseases |